Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Biopharmaceutical import value in South Korea 2012-2017

Value of biopharmaceuticals imported into South Korea from 2012 to 2017 (in million U.S. dollars)

by Won So, last edited May 23, 2019
Biopharmaceutical import value in South Korea 2012-2017 This statistic illustrates the value of biopharmaceuticals imported into South Korea from 2012 to 2017. In 2017, the import value of biopharmaceuticals in South Korea amounted to around 1.04 trillion U.S. dollars, increased from 911 million in the previous year.
Show more

Value of biopharmaceuticals imported into South Korea from 2012 to 2017 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Amgen"
  • Global positioning
The most important statistics
  • Revenue and income
  • Expenditure
  • Other key figures
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.